Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atezolizumab and Bevacizumab with FOLFOX in Colorectal Liver Metastases
NCT03698461Phase 2Completed
- Sponsor
- Asan Medical Center
- Start
- May 2019
- Primary completion
- Dec 2021
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of atezolizumab in Colorectal cancer with liver metastases (CRLM), sponsored by Asan Medical Center. Started May 2019; status: completed.
02
Drugs
atezolizumab
03
Conditions
Colorectal cancer with liver metastases (CRLM)
Beyond the preview
Go deeper on NCT03698461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03698461.